Transaction DateRecipientSharesTypePriceValue
Cyclacel Pharmaceuticals
Cyclacel Pharmaceuticals logo

Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 7/10.

Cyclacel Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. Its products include CYC065, seliciclib, and sapacitabine. The company was founded by Ronald J. Berenson, David Philip Lane, and David Glover in 1996.

Ticker: CYCC
Sector: Health Technology
Industry: Biotechnology
SEC Central Index Key (CIK): 1130166
Employees: 12
Exchange: NASDAQ
Auditor Opinion:

Disclosure Language changes
Red Flags